Eli Lilly CEO says Medicare price negotiations could harm drug development
David Ricks, CEO, Eli LillyScott Mlyn | CNBCEli Lilly CEO David Ricks on Tuesday said Medicare price negotiations, which aim to cut costs for older Americans, could potentially harm drug development. "I'm really worried about the harm this…